Summary
This report by Hindenburg Research examines EHang, a China-based eVTOL company listed on Nasdaq, raising serious concerns about its business practices, financial health, and the credibility of its customer orders. The report questions the company's purported preorders and highlights potential risks for investors and passengers.
Who is EHang
EHang Holdings Limited is a China-based manufacturer of electric vertical take-off and landing (eVTOL) aircraft, established in 2014 and publicly traded on Nasdaq since 2019. The company aims to commercialize autonomous passenger-grade air taxis alongside applications in firefighting, organ transport, and logistics, focusing primarily on short and long-range eVTOL models EH216 and VT-30.
Key Points from Report
Market Position and Financial Concerns
- EHang is valued at about $903 million market cap but trades at a premium of roughly 50.3x its tangible book value, well above competitors such as Joby Aviation (4.1x) and Archer Aviation (5.0x).
- Despite its high valuation, EHang’s flagship EH216 aircraft performs poorly compared to rivals in range (30 km), payload (220 kg), and flight time (25 minutes).
- The company has underinvested heavily in R&D, spending $97.4 million cumulatively compared to Joby’s $761.9 million and Archer’s $381.1 million.
- EHang’s cash reserves are critically low at $44.9 million, versus the hundreds of millions held by competitors, raising concerns about runway in this capital-intensive industry.
- In July 2023, it raised $23 million led by Lee Soo Man, a South Korean music producer with a controversial legal history including prison sentences for embezzlement.
Questionable Certification and Flight Restrictions
- EHang’s EH216-S received a Type Certification from China's CAAC with severe operational restrictions such as no night flights, no flying over water, no flying in dense urban areas, and mandatory line-of-sight with the ground crew.
- These restrictions effectively disqualify EHang’s aircraft from many of its indicated commercial use cases including urban air taxis and emergency transport.
- Experts suggest that overcoming these limitations would require an extensive and costly redesign costing over a billion dollars to meet a higher class of certification.
Preorder Book and Sales Doubts
- Over 92% of EHang’s claimed 1,300+ unit preorder book appears to be based on dead deals, failed partnerships, or questionable customers such as newly formed entities with no aviation experience or relevant operations.
- The largest order, from United Therapeutics, is a 1,000 unit preorder representing 74% of total preorders, but the partnership appears abandoned and United Therapeutics has sold its entire stake in EHang.
- Other key preorders from Prestige Aviation, AirX, and Shenzhen Boling Holdings Group have dubious legitimacy, with Prestige being newly formed with minimal capital and no authentic aviation operations, AirX primarily acting as a reseller without real buyers, and Boling having no registered employees and operating from a residential building.
- Alleged sales to Kunxiang, supposedly an arm’s length customer, were found to be related party transactions connected to EHang’s pre-IPO investors, contradicting company statements and raising red flags on fake revenue recognition.
- EHang has regularly written down millions in accounts receivables suggesting that reported revenue might not have been collected.
Activ8 Finance Analysis
This detailed investigation by Hindenburg Research raises significant caution regarding EHang’s business viability and operational integrity. The company’s overstated preorder book, significant regulatory limitations on its aircraft, minimal R&D investment, questionable partnerships, and signs of artificially inflated revenue all suggest high risks. Such findings highlight the challenges in the eVTOL sector and the critical importance of transparency, especially when public safety and investor capital are involved.